Potential Dangers of Using E-Cigarettes on Oral Health

Nov.24.2022
Potential Dangers of Using E-Cigarettes on Oral Health
Electronic cigarettes contain harmful chemicals. Studies suggest they increase the risk of tooth decay and respiratory problems.

Electronic cigarettes contain potentially harmful chemicals. While research on electronic cigarettes is growing, the full extent of their impact on health, particularly oral health, remains unclear. A new study has found that using electronic cigarettes increases the risk of tooth decay.


Although the results are preliminary, the authors of the study recommend adding electronic cigarettes to dental health surveys and considering them as a factor in increasing the risk of tooth decay.


Electronic cigarettes, also known as e-cigarettes, are battery-powered devices that use a heating element to create an aerosol from liquid. This aerosol is then inhaled into the lungs. E-cigarette liquids can contain nicotine or not and may also contain derivatives of cannabis.


It is estimated that in 2018, approximately 58.1 million people worldwide used electronic cigarette products.


The aerosol in e-cigarettes contains potentially harmful substances, including nicotine, heavy metals, and flavorings such as diacetyl - a chemical linked to lung impairment and disease. According to the Centers for Disease Control and Prevention, more research is needed to fully understand the health impacts of e-cigarette products.


A small case study with four participants in 2022 found a correlation between using electronic cigarettes for 3-8 years and symptomatic chronic lung diseases, including small airway fibrosis and constrictive bronchiolitis. However, the study's authors also noted that symptom improvement was observed in participants who had stopped using electronic cigarettes.


In addition, recent research has found a link between the use of e-cigarettes and damage to blood vessels.


Statement:


This article was compiled based on information from third-party sources and is intended for industry professionals for educational purposes and exchange of knowledge.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity or accuracy of the content. The compilation of this article is only intended for industry exchange and research purposes.


Due to limitations in the translator's ability, the translated article may not accurately reflect the original text. Please refer to the original article for accuracy.


2FIRSTS maintains full alignment with the Chinese government in regards to any domestic, Hong Kong, Macau, Taiwan, and foreign statements and positions.


The copyright for compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

U.S. FDA Updates PMTA and SE Application Processes, Releases New Submission Forms and Validation Tools
U.S. FDA Updates PMTA and SE Application Processes, Releases New Submission Forms and Validation Tools
The U.S. FDA has released six new forms for submitting applications for new tobacco products, covering both the Premarket Tobacco Product Application (PMTA) and Substantial Equivalence (SE) pathways. Starting July 6, 2025, all applicants will be required to use the updated forms, as previous versions will no longer be accepted.
Jun.09 by 2FIRSTS.ai
OXVA Partners with U.S. Chip Firm to Launch Next-Gen XLIM PRO 2 DNA
OXVA Partners with U.S. Chip Firm to Launch Next-Gen XLIM PRO 2 DNA
Vaping brand OXVA has partnered with U.S.-based chipmaker Evolv to develop a pod device powered by Evolv’s DNA chip. The enhanced temperature control feature is designed to prevent dry hits, a common issue in pod systems.
May.20 by 2FIRSTS.ai
Poland to Ban Disposable E-Cigs and Flavored Nicotine Pouches
Poland to Ban Disposable E-Cigs and Flavored Nicotine Pouches
Poland's Ministry of Health plans to ban disposable e-cigarettes and flavored nicotine pouches, and prohibit e-cigarette sales to anyone under 18. The draft has been approved by the government's legislative group and backed unanimously by the parliamentary health committee.
May.08 by 2FIRSTS.ai
Malaysia's Kelantan State Has Banned E-Cigarettes for a Decade, but Illegal Sales Persist
Malaysia's Kelantan State Has Banned E-Cigarettes for a Decade, but Illegal Sales Persist
Malaysia’s Kelantan state has enforced a total ban on e-cigarettes since 2015. Despite the ban, illegal sales persist, with 16 shops shut down so far this year, compared to 67 in 2024.
May.15 by 2FIRSTS.ai
BAT Plans to Appoint New Chairman, Successor Expected by 2026
BAT Plans to Appoint New Chairman, Successor Expected by 2026
British American Tobacco is seeking a successor for chairman Luc Jobin, who will step down in 2026 due to governance rules.
Jun.10 by 2FIRSTS.ai
Reuters: Tariffs and Crackdowns Drive Sharp Decline in U.S. Supply of Chinese E-Cigarettes like Geek Bar
Reuters: Tariffs and Crackdowns Drive Sharp Decline in U.S. Supply of Chinese E-Cigarettes like Geek Bar
Reuters reports that U.S. imports of Chinese e-cigarettes have fallen sharply due to high tariffs and stricter FDA crackdowns. Brands like Geek Bar face major supply shortages and rising prices, though demand remains strong. Some Chinese makers are moving production to Southeast Asia to avoid regulatory pressure.
Jun.09 by 2FIRSTS.ai